A meta-analysis of pregnancy-related outcomes and complications in women with polycystic ovary syndrome undergoing IVF

REPRODUCTIVE BIOMEDICINE ONLINE

卷:39

Review

Sha, Tingting¹  Wang, Xiaojuan²  Cheng, Wenwei³  Yan, Yan¹ 

[1] Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Med Stat, Changsha, Hunan, Peoples R China

[2] Reprod & Genet Hosp CITIC Xiangya, Changsha, Hunan, Peoples R China

[3] Cent South Univ, Xiangya Hosp 3, Changsha, Hunan, Peoples R China

关键词: IVF;    Polycystic ovary syndrome;    Pregnancy complications;    Pregnancy outcomes;   

DOI  :  10.1016/j.rbmo.2019.03.203

来源: Elsevier

【 摘 要 】

This meta-analysis aimed to study whether pregnancy-related outcomes and complications differed between patients with polycystic ovary syndrome (PCOS) and those with other causes of infertility who had undergone IVF. A systematic search of PubMed, Embase, the Cochrane Library and Chinese databases was carried out to identify relevant studies published before July 2018. Outcomes were expressed as odds ratios (OR) and 95% confidence intervals (CI). Subgroup analyses and sensitivity analyses were also conducted. Twenty-nine studies were identified for inclusion. Women with PCOS had higher risks of miscarriage (OR 1.41, 95% CI 1.04-1.91), ovarian hyperstimulation syndrome (OR 4.96, 95% CI 3.73-6.60), gestational diabetes mellitus (OR 2.67, 95% CI 1.43-4.98), pregnancy-induced hypertension (OR 2.06, 95% CI 1.45-2.91), preterm birth (OR 1.60, 95% CI 1.25-2.04) and large-for-gestational-age babies (OR 2.10, 95% CI 1.01-4.37). Women with PCOS showed similar rates of clinical pregnancy, multiple pregnancy, ectopic pregnancy, small for gestational age and congenital malformations, and a higher live birth rate, compared with women without PCOS. This study provides an update on and comprehensive evidence to support the observation that despite the fact that PCOS patients achieve a better live birth rate, physicians should continue to consider them to be at high risk of adverse pregnancy-related outcomes.

【 授权许可】

Free